Comparison of template-matching and singular-spectrum-analysis methods for imaging implanted brachytherapy seeds
暂无分享,去创建一个
J. Mamou | S. Alam | E. Feleppa | S. Ramachandran | A. Kalisz | Jonathan Mamou | S. Ramachandran | A. Kalisz | S. K. Alam | E. J. Feleppa
[1] B W Corn,et al. Effect of edema on the post-implant dosimetry of an I-125 prostate implant: a case study. , 1997, International journal of radiation oncology, biology, physics.
[2] P. Roberson,et al. Source placement error for permanent implant of the prostate. , 1997, Medical physics.
[3] N. Yue,et al. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. , 1998, International Journal of Radiation Oncology, Biology, Physics.
[4] R. Stock,et al. A dose-response study for I-125 prostate implants. , 1998, International journal of radiation oncology, biology, physics.
[5] P L Roberson,et al. Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants. , 1997, International journal of radiation oncology, biology, physics.
[6] Jonathan Mamou,et al. Angle-dependent ultrasonic detection and imaging of brachytherapy seeds using singular spectrum analysis. , 2008, The Journal of the Acoustical Society of America.
[7] G. P. King,et al. Extracting qualitative dynamics from experimental data , 1986 .
[8] W. C. de Albuquerque Pereira,et al. Performance of ultrasound echo decomposition using singular spectrum analysis. , 2001, Ultrasound in medicine & biology.
[9] H. Holm,et al. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. , 1983, The Journal of urology.
[10] S. L. Bridal,et al. Singular spectrum analysis applied to backscattered ultrasound signals from in vitro human cancellous bone specimens , 2004, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[11] C. Clifton Ling,et al. Determining source strength and source distribution for a transperineal prostate implant , 1996 .
[12] F M Waterman,et al. Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants. , 1996, International journal of radiation oncology, biology, physics.
[13] Jonathan Mamou,et al. Singular spectrum analysis applied to ultrasonic detection and imaging of brachytherapy seeds. , 2007, The Journal of the Acoustical Society of America.
[14] J Roy,et al. Short-term morbidity from CT-planned transperineal I-125 prostate implants. , 1993, International journal of radiation oncology, biology, physics.
[15] K. Wallner,et al. CT-based dosimetry for transperineal I-125 prostate brachytherapy. , 1997, International journal of radiation oncology, biology, physics.
[16] Ernest J. Feleppa,et al. Novel methods of analyzing radio-frequency echo signals for the purpose of imaging brachytherapy seeds used to treat prostate cancer , 2002, SPIE Medical Imaging.
[17] J Roy,et al. Treatment-related symptoms during the first year following transperineal 125I prostate implantation. , 1994, International journal of radiation oncology, biology, physics.
[18] J J Prete,et al. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy. , 1998, International journal of radiation oncology, biology, physics.
[19] S Nag,et al. Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration. , 1995, Urology.
[20] L. Potters,et al. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. , 2001, International journal of radiation oncology, biology, physics.
[21] H. Hricak,et al. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. , 1996, International journal of radiation oncology, biology, physics.